Artificial Intelligence
Global Radiation Therapy Equipment Market to Reach US$6.6 Billion by the Year 2026
New York, Oct. 11, 2021 (GLOBE NEWSWIRE) — Reportlinker.com announces the release of the report “Global Radiation Therapy Equipment Industry” – https://www.reportlinker.com/p05442588/?utm_source=GNW
By using high-energy radiation from sources such as X-rays, neutrons, protons, and gamma rays, radiotherapy kills cancer-affected tissues or prevents multiplication of cancer cells in the body. Growth in the global market continues to be driven by the constant increase in the number of cancer patients across the world and the increasing adoption of radiation therapy for treatment of cancer. Advancing cancer treatment technologies and increasing availability of reimbursement coverage for radiotherapy treatments is expected to favor market growth. Also driving growth is the steadily expanding elderly population and rising incidence of cancer in this age group. Reducing cost of treatment in several developed nations, and increasing government and private investments in research and development associated with cancer treatment are fostering growth in the global radiotherapy equipment market. The recent advancements and innovations in the radiation therapy space have led to the development of effective treatments, a good prognosis, and reduced side effects during the treatment. There are significant developments observed in the areas of stereotactic body radiation therapy (SBRT), intensity-modulated radiation therapy (IMRT), nanotechnology, 4D imaging, particle therapy, which are further improving the radiotherapy treatments.
Amid the COVID-19 crisis, the global market for Radiation Therapy Equipment estimated at US$5.2 Billion in the year 2020, is projected to reach a revised size of US$6.6 Billion by 2026, growing at a CAGR of 4.3% over the analysis period. External Beam Radiation Therapy, one of the segments analyzed in the report, is projected to grow at a 4.5% CAGR to reach US$5.9 Billion by the end of the analysis period. After a thorough analysis of the business implications of the pandemic and its induced economic crisis, growth in the Internal Radiation Therapy segment is readjusted to a revised 3.5% CAGR for the next 7-year period. This segment currently accounts for a 9.5% share of the global Radiation Therapy Equipment market. The external beam radiation therapy involves transmission of radiation through a machine that is placed outside the body. Incidence of cancer cases, and increasing patient and physician awareness about procedures, ongoing improvement in diagnostic techniques, and availability of advanced diagnostic techniques are driving segment growth. Internal radiation therapy, also termed as brachytherapy, involves placing radioactive material or implant through a catheter, at the tumor site and at surrounding tissue. Growth in the segment is led primarily by the expanding pool of cancer patients.
The U.S. Market is Estimated at $1.9 Billion in 2021, While China is Forecast to Reach $546.7 Million by 2026
The Radiation Therapy Equipment market in the U.S. is estimated at US$1.9 Billion in the year 2021. The country currently accounts for a 36.7% share in the global market. China, the world`s second largest economy, is forecast to reach an estimated market size of US$546.7 Million in the year 2026 trailing a CAGR of 5.8% through the analysis period. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 3.3% and 3.5% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 4.2% CAGR while Rest of European market (as defined in the study) will reach US$583.3 Million by the end of the analysis period. Developed regions including the US, Canada, Japan and Europe represent the leading regional markets for radiotherapy equipment due largely to the presence of well-established and advanced healthcare infrastructure facilities and higher adoption of advanced radiation therapies for cancer treatment. In developing countries, growth will be driven by increasing incidence of cancer and the consequent growth in demand for cancer treatment techniques including radiation therapy.
Systemic Radiation Therapy Segment $401.7 Million by 2026
Systemic radiation therapy entails use of radioactive materials like iodine-131 or strontium-89 that travel through blood to eliminate cancerous cells. Systemic radiotherapy market is being driven by rapid changes in cancer treatment technologies and sustained increase in the number of cancer patients, worldwide. Growth is also being fueled by the technique`s growing application in areas such as bone metastasis, thyroid cancer, non-Hodgkin`s lymphoma and radio immunotherapy. In the global Systemic Radiation Therapy segment, USA, Canada, Japan, China and Europe will drive the 3% CAGR estimated for this segment. These regional markets accounting for a combined market size of US$283.4 Million in the year 2020 will reach a projected size of US$349.6 Million by the close of the analysis period. China will remain among the fastest growing in this cluster of regional markets. Led by countries such as Australia, India, and South Korea, the market in Asia-Pacific is forecast to reach US$37.9 Million by the year 2026, while Latin America will expand at a 3.9% CAGR through the analysis period.
Select Competitors (Total 54 Featured)
- Accuray Incorporated
- BrainLab AG
- Elekta AB
- GE Healthcare
- Hitachi America, Ltd.
- IBA Group
- Nordion, Inc.
- Philips Healthcare
- RaySearch Laboratories AB
- Sumitomo Heavy Industries Ltd.
- Varian Medical Systems, Inc.
Read the full report: https://www.reportlinker.com/p05442588/?utm_source=GNW
I. METHODOLOGY
II. EXECUTIVE SUMMARY
1. MARKET OVERVIEW
Impact of COVID-19 and a Looming Global Recession
2020 Marked as a Year of Disruption & Transformation
EXHIBIT 1: World Economic Growth Projections (Real GDP, Annual
% Change) for 2020 through 2022
Pandemic Impacts Radiation Oncology Services
Amidst the COVID-19 Pandemic, Radiation Oncology Centers
Implement Workflow Changes
Potential Role for Radiation Therapy in Treatment of COVID-19
AI, Machine Learning & Other IT Technologies to Tackle
Pandemic-Led Cancer Backlogs
Potential Role of Low-Dose Radiation Therapy for COVID-19
Treatment
Radiation Therapy: An Effective, Affordable, Non-Surgical
Treatment Option for Cancer Patients
Radiation Therapy Equipment: Enabling Best-in-Class Cancer Care
Global Market Prospects & Outlook
EXHIBIT 2: Utilization Rate (%) of Radiation Therapy by Type of
Cancer
Cance
Replacement Demand Drives Revenue Growth in Developed Regions
Developing Regions to Spearhead Future Growth
Competition
EXHIBIT 3: Global Radiation Therapy Equipment Market Breakdown
of Revenues (in %) by Leading Players for 2020
EXHIBIT 4: Gross Order Value (in $ Million) of Select Companies
in the Radiation Therapy Equipment Market: 2020
LINACs Market: Dominated by Variant and Elekta
EXHIBIT 5: Global Linear Accelerators (LINACs) Market:
Percentage Breakdown of Installed Base by Leading Players for
2019
EXHIBIT 6: Global Linear Accelerators (LINACs) Market:
Percentage Breakdown of New Orders by Leading Players for 2019
IBA: The Predominant Player in Proton Therapy Equipment Market
EXHIBIT 7: Global Proton Therapy Market Breakdown by Number of
PT Rooms (in %) by Leading Players: As of H1 2020
Treatment Planning Systems Market
EXHIBIT 8: Global Treatment Planning Systems Market Share
Breakdown of Sales (in %) by Leading Players for 2020
World Brands
Recent Market Activity
2. FOCUS ON SELECT PLAYERS
3. MARKET TRENDS & DRIVERS
Rising Incidence of Cancer & Need to Reduce Cancer-Related
Mortality: Cornerstone for Present & Future Growth
EXHIBIT 9: Global Cancer Incidence: Number of New Cancer Cases
in Million for the Years 2018, 2020, 2025, 2030, 2035 and 2040
EXHIBIT 10: Global Number of New Cancer Cases and Cancer-
related Deaths by Cancer Site for 2020
EXHIBIT 11: Number of New Cancer Cases and Deaths (in Million)
by Region for 2020
Underserved Demand for Radiation Oncology Therapy Drives Market
EXHIBIT 12: Projected Need for Radiation Oncology Centers,
Radiation Oncologists, Medical Physicists and Radiation
Technologists by the Year 2035
EXHIBIT 13: Percentage of Cancer Patients Treated with
Radiotherapy in Select Countries
Increasing Healthcare Expenditure Creates Conducive Environment
EXHIBIT 14: World Healthcare Expenditure (In US$ Trillion) for
the Years for 2017, 2019, 2021, 2023
External Beam Radiotherapy Equipment: The Largest Product Category
Linear Accelerator (LINAC): A Vital Constituent of EBRT
LINACs Replace Conventional Radiotherapy Equipment
MRI-LINACs Revolutionizes Cancer Care
EXHIBIT 15: Penetration of LINACs Worldwide: Number of LINACs
Per Million Population in Select Countries for 2019
Proton Therapy Revolutionizes Radiation Therapy Space
EXHIBIT 16: Global Proton Therapy Market by Region/Country
(in %) for 2020
Intensely-Modulated Proton Therapy (IMPT): The Future of Proton
Therapy
High Cost: A Barrier to Adoption
Systemic Radiation Therapy Equipment: A Small Yet Growing Market
Internal Radiation Therapy Equipment: Overview
Intensity Modulated Radiation Therapy (IMRT) Equipment Help
Hospitals Improve Outcomes
Stereotactic Radio Surgery Treatment Gaining Traction
Adaptive Radiation Therapy (ART) Gains Significance
Image Guided Radiotherapy (IGRT) Grows in Prominence
Surface Guided Radiation Therapy Systems Market: Stable Growth
Outlook
Oncology Information Systems (OIS): Assisting Management of
Complex and Advanced Radiation Therapies
Data-Intensive Radiation Oncology Promotes OIS Connection to EHRs
Advancing Radiation Therapy Raises Importance of Treatment
Planning Systems
Progressive Advancements Augment Use Case of Treatment Planning
Platforms
Increasing Role of Imaging in Treatment Planning
Radiotherapy Positioning Devices Market: Poised for Growth
Innovative Therapies Revolutionize Radiation Treatment
Flash Radiation Therapy: Future Trend
Intraoperative Radiation Therapy Market
Technological Innovations Spur Radiation Therapy Equipment Market
Hybrid Systems Enable Superior Treatment Efficacy
Computer Simulators Improve Radiation Therapy Outcomes
Need to Boost Productivity Accelerates Deployment of High-Tech
Equipment
Personalized Radiation Therapy: The Way Forward
Promising Role of Brachytherapy Device and Intensity-Modulated
Radiation for Eye Cancer Treatment
Select Innovations in Radiation Therapy Space
Artificial Intelligence and Machine Learning in Radiotherapy
Treatment
Technology-driven Research for Development in Radiotherapy
Refurbished Radiation Therapy Equipment: Changing with the Times
Expanding Aging Population at High Risk of Cancer to Benefit
Market Expansion
EXHIBIT 17: Global Aging Population Statistics for the 65+ Age
Group in Million by Geographic Region for the Years 2019,
2025, 2035 and 2050
EXHIBIT 18: Elderly Population (65+ Years) as a % of Total
Population by Developed, Less Developed and Least Developed
Regions: 2019 & 2030
Challenges Confronting Radiation Therapy Equipment Market
Radiation Therapy: Product Overview
Types of Radiation Therapy
External Beam Radiation Therapy (EBRT/XRT) or Teletherapy
Internal Beam Radio Therapy/Brachytherapy
Systemic Radioisotope Therapy (RIT)
Other Forms of Radiation Therapy
Linear Accelerators (LINACs)
Radiation Therapy Simulator
Treatment Planning System: An Innovative Technique in Radiation
Therapy
Radiotherapy Accessories
Tumor Localization and Treatment Simulation Devices
Patient Restraint and Repositioning Devices
Field-Shaping Devices
Dose-Modifying Devices
4. GLOBAL MARKET PERSPECTIVE
Table 1: World Current & Future Analysis for Radiation Therapy
Equipment by Geographic Region – USA, Canada, Japan, China,
Europe, Asia-Pacific, Latin America, Middle East and Africa
Markets – Independent Analysis of Annual Sales in US$ Thousand
for Years 2020 through 2027 and % CAGR
Table 2: World Historic Review for Radiation Therapy Equipment
by Geographic Region – USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets –
Independent Analysis of Annual Sales in US$ Thousand for Years
2012 through 2019 and % CAGR
Table 3: World 15-Year Perspective for Radiation Therapy
Equipment by Geographic Region – Percentage Breakdown of Value
Sales for USA, Canada, Japan, China, Europe, Asia-Pacific,
Latin America, Middle East and Africa Markets for Years 2012,
2021 & 2027
Table 4: World Current & Future Analysis for External Beam
Radiation Therapy by Geographic Region – USA, Canada, Japan,
China, Europe, Asia-Pacific, Latin America, Middle East and
Africa Markets – Independent Analysis of Annual Sales in US$
Thousand for Years 2020 through 2027 and % CAGR
Table 5: World Historic Review for External Beam Radiation
Therapy by Geographic Region – USA, Canada, Japan, China,
Europe, Asia-Pacific, Latin America, Middle East and Africa
Markets – Independent Analysis of Annual Sales in US$ Thousand
for Years 2012 through 2019 and % CAGR
Table 6: World 15-Year Perspective for External Beam Radiation
Therapy by Geographic Region – Percentage Breakdown of Value
Sales for USA, Canada, Japan, China, Europe, Asia-Pacific,
Latin America, Middle East and Africa for Years 2012, 2021 &
2027
Table 7: World Current & Future Analysis for Internal Radiation
Therapy by Geographic Region – USA, Canada, Japan, China,
Europe, Asia-Pacific, Latin America, Middle East and Africa
Markets – Independent Analysis of Annual Sales in US$ Thousand
for Years 2020 through 2027 and % CAGR
Table 8: World Historic Review for Internal Radiation Therapy
by Geographic Region – USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets –
Independent Analysis of Annual Sales in US$ Thousand for Years
2012 through 2019 and % CAGR
Table 9: World 15-Year Perspective for Internal Radiation
Therapy by Geographic Region – Percentage Breakdown of Value
Sales for USA, Canada, Japan, China, Europe, Asia-Pacific,
Latin America, Middle East and Africa for Years 2012, 2021 &
2027
Table 10: World Current & Future Analysis for Systemic
Radiation Therapy by Geographic Region – USA, Canada, Japan,
China, Europe, Asia-Pacific, Latin America, Middle East and
Africa Markets – Independent Analysis of Annual Sales in US$
Thousand for Years 2020 through 2027 and % CAGR
Table 11: World Historic Review for Systemic Radiation Therapy
by Geographic Region – USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets –
Independent Analysis of Annual Sales in US$ Thousand for Years
2012 through 2019 and % CAGR
Table 12: World 15-Year Perspective for Systemic Radiation
Therapy by Geographic Region – Percentage Breakdown of Value
Sales for USA, Canada, Japan, China, Europe, Asia-Pacific,
Latin America, Middle East and Africa for Years 2012, 2021 &
2027
Table 13: World Current & Future Analysis for Hospitals by
Geographic Region – USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets –
Independent Analysis of Annual Sales in US$ Thousand for Years
2020 through 2027 and % CAGR
Table 14: World Historic Review for Hospitals by Geographic
Region – USA, Canada, Japan, China, Europe, Asia-Pacific, Latin
America, Middle East and Africa Markets – Independent Analysis
of Annual Sales in US$ Thousand for Years 2012 through 2019 and
% CAGR
Table 15: World 15-Year Perspective for Hospitals by Geographic
Region – Percentage Breakdown of Value Sales for USA, Canada,
Japan, China, Europe, Asia-Pacific, Latin America, Middle East
and Africa for Years 2012, 2021 & 2027
Table 16: World Current & Future Analysis for Other End-Uses by
Geographic Region – USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets –
Independent Analysis of Annual Sales in US$ Thousand for Years
2020 through 2027 and % CAGR
Table 17: World Historic Review for Other End-Uses by
Geographic Region – USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets –
Independent Analysis of Annual Sales in US$ Thousand for Years
2012 through 2019 and % CAGR
Table 18: World 15-Year Perspective for Other End-Uses by
Geographic Region – Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America,
Middle East and Africa for Years 2012, 2021 & 2027
III. MARKET ANALYSIS
UNITED STATES
United States: The Prime Market for Radiation Therapy Equipment
Radiation Therapy in the US: An Overview
Rising Incidence of Cancer & Shift towards Non-Invasive
Procedures Widens Market Prospects
EXHIBIT 19: Estimated Number of New Cancer Cases in the US by
Gender and Affected Site for 2021
EXHIBIT 20: Estimated Number of Cancer-Related Deaths in the US
by Gender and Body Site for 2021
EXHIBIT 21: Estimated Number of New Cancer Cases in the US by
State for 2021
EXHIBIT 22: Estimated Number of Cancer-Related Deaths in the US
by State for 2021
Rising Spending on Cancer Care
EXHIBIT 23: Cost of Cancer Care in the US: Lifetime Healthcare
Spending (in $) by Cancer Type
Replacements Drive Unit Installations
Innovations Propel Market Growth
External Radiation Therapy: The Most Common Type of RT
Treatment for Cancer
Proton Therapy Gaining Traction in Cancer Care
IMRT: Enabling Precise Treatments for Specific Cancers
Systemic Radiotherapy Market: High Therapy Costs Limit Growth
Opportunities
Treatment Planning Software Holds Prominence
Reimbursement Rates for Cancer Treatment with Radiation
Indicate Notable Disparity among States
Oncology Care Model to Improve Quality and Reduce Financial
Toxicity of Cancer Care
Competition
EXHIBIT 24: US Radiotherapy Equipment Market Breakdown by
Leading Players: 2020
EXHIBIT 25: US Proton Therapy Equipment Market Share Breakdown
of Installed Base by Company: 2020
Market Analytics
Table 19: USA Current & Future Analysis for Radiation Therapy
Equipment by Type – External Beam Radiation Therapy, Internal
Radiation Therapy and Systemic Radiation Therapy – Independent
Analysis of Annual Sales in US$ Thousand for the Years 2020
through 2027 and % CAGR
Table 20: USA Historic Review for Radiation Therapy Equipment
by Type – External Beam Radiation Therapy, Internal Radiation
Therapy and Systemic Radiation Therapy Markets – Independent
Analysis of Annual Sales in US$ Thousand for Years 2012 through
2019 and % CAGR
Table 21: USA 15-Year Perspective for Radiation Therapy
Equipment by Type – Percentage Breakdown of Value Sales for
External Beam Radiation Therapy, Internal Radiation Therapy and
Systemic Radiation Therapy for the Years 2012, 2021 & 2027
Table 22: USA Current & Future Analysis for Radiation Therapy
Equipment by End-Use – Hospitals and Other End-Uses –
Independent Analysis of Annual Sales in US$ Thousand for the
Years 2020 through 2027 and % CAGR
Table 23: USA Historic Review for Radiation Therapy Equipment
by End-Use – Hospitals and Other End-Uses Markets – Independent
Analysis of Annual Sales in US$ Thousand for Years 2012 through
2019 and % CAGR
Table 24: USA 15-Year Perspective for Radiation Therapy
Equipment by End-Use – Percentage Breakdown of Value Sales for
Hospitals and Other End-Uses for the Years 2012, 2021 & 2027
CANADA
Market Overview
EXHIBIT 26: Number of New Cancer Cases by Cancer Type in
Canada: 2020
Market Analytics
Table 25: Canada Current & Future Analysis for Radiation
Therapy Equipment by Type – External Beam Radiation Therapy,
Internal Radiation Therapy and Systemic Radiation Therapy –
Independent Analysis of Annual Sales in US$ Thousand for the
Years 2020 through 2027 and % CAGR
Table 26: Canada Historic Review for Radiation Therapy
Equipment by Type – External Beam Radiation Therapy, Internal
Radiation Therapy and Systemic Radiation Therapy Markets –
Independent Analysis of Annual Sales in US$ Thousand for Years
2012 through 2019 and % CAGR
Table 27: Canada 15-Year Perspective for Radiation Therapy
Equipment by Type – Percentage Breakdown of Value Sales for
External Beam Radiation Therapy, Internal Radiation Therapy and
Systemic Radiation Therapy for the Years 2012, 2021 & 2027
Table 28: Canada Current & Future Analysis for Radiation
Therapy Equipment by End-Use – Hospitals and Other End-Uses –
Independent Analysis of Annual Sales in US$ Thousand for the
Years 2020 through 2027 and % CAGR
Table 29: Canada Historic Review for Radiation Therapy
Equipment by End-Use – Hospitals and Other End-Uses Markets –
Independent Analysis of Annual Sales in US$ Thousand for Years
2012 through 2019 and % CAGR
Table 30: Canada 15-Year Perspective for Radiation Therapy
Equipment by End-Use – Percentage Breakdown of Value Sales for
Hospitals and Other End-Uses for the Years 2012, 2021 & 2027
JAPAN
Market Overview
EXHIBIT 27: Cancer Related Incidence and Deaths in Japan: 2020
Competition
EXHIBIT 28: Japanese LINACs Market Breakdown by Competitor
(in %) for 2020
EXHIBIT 29: Japanese Proton Therapy Equipment Market Share
Breakdown of Leading Players: 2020
Market Analytics
Table 31: Japan Current & Future Analysis for Radiation Therapy
Equipment by Type – External Beam Radiation Therapy, Internal
Radiation Therapy and Systemic Radiation Therapy – Independent
Analysis of Annual Sales in US$ Thousand for the Years 2020
through 2027 and % CAGR
Table 32: Japan Historic Review for Radiation Therapy Equipment
by Type – External Beam Radiation Therapy, Internal Radiation
Therapy and Systemic Radiation Therapy Markets – Independent
Analysis of Annual Sales in US$ Thousand for Years 2012 through
2019 and % CAGR
Table 33: Japan 15-Year Perspective for Radiation Therapy
Equipment by Type – Percentage Breakdown of Value Sales for
External Beam Radiation Therapy, Internal Radiation Therapy and
Systemic Radiation Therapy for the Years 2012, 2021 & 2027
Table 34: Japan Current & Future Analysis for Radiation Therapy
Equipment by End-Use – Hospitals and Other End-Uses –
Independent Analysis of Annual Sales in US$ Thousand for the
Years 2020 through 2027 and % CAGR
Table 35: Japan Historic Review for Radiation Therapy Equipment
by End-Use – Hospitals and Other End-Uses Markets – Independent
Analysis of Annual Sales in US$ Thousand for Years 2012 through
2019 and % CAGR
Table 36: Japan 15-Year Perspective for Radiation Therapy
Equipment by End-Use – Percentage Breakdown of Value Sales for
Hospitals and Other End-Uses for the Years 2012, 2021 & 2027
CHINA
Market Overview
EXHIBIT 30: Number of New Cancer Cases for Both Sexes by Cancer
Type for 2020
Competition
EXHIBIT 31: Chinese Radiation Therapy Equipment Market
Breakdown by Leading Companies: 2020
Market Analytics
Table 37: China Current & Future Analysis for Radiation Therapy
Equipment by Type – External Beam Radiation Therapy, Internal
Radiation Therapy and Systemic Radiation Therapy – Independent
Analysis of Annual Sales in US$ Thousand for the Years 2020
through 2027 and % CAGR
Table 38: China Historic Review for Radiation Therapy Equipment
by Type – External Beam Radiation Therapy, Internal Radiation
Therapy and Systemic Radiation Therapy Markets – Independent
Analysis of Annual Sales in US$ Thousand for Years 2012 through
2019 and % CAGR
Table 39: China 15-Year Perspective for Radiation Therapy
Equipment by Type – Percentage Breakdown of Value Sales for
External Beam Radiation Therapy, Internal Radiation Therapy and
Systemic Radiation Therapy for the Years 2012, 2021 & 2027
Table 40: China Current & Future Analysis for Radiation Therapy
Equipment by End-Use – Hospitals and Other End-Uses –
Independent Analysis of Annual Sales in US$ Thousand for the
Years 2020 through 2027 and % CAGR
Table 41: China Historic Review for Radiation Therapy Equipment
by End-Use – Hospitals and Other End-Uses Markets – Independent
Analysis of Annual Sales in US$ Thousand for Years 2012 through
2019 and % CAGR
Table 42: China 15-Year Perspective for Radiation Therapy
Equipment by End-Use – Percentage Breakdown of Value Sales for
Hospitals and Other End-Uses for the Years 2012, 2021 & 2027
EUROPE
Market Facts & Figures
Amidst COVID-19 Outbreak, EU Witnesses Lags in the Provision of
Radiation Therapy
Rising Cancer Incidence Sustains Growth in Radiation Therapy
Equipment Market
EXHIBIT 32: Number of New Cancer Cases in Europe: 2012, 2018,
and 2025
EXHIBIT 33: Number of Radiotherapy Centers by Type in Select
European Countries
Competition
EXHIBIT 34: EMEA Radiation Therapy Equipment Market by Leading
Players for 2020
EXHIBIT 35: European Proton Therapy Equipment Market Share
Breakdown (in %) by Competitors: 2020
Market Analytics
Table 43: Europe Current & Future Analysis for Radiation
Therapy Equipment by Geographic Region – France, Germany,
Italy, UK, Spain, Russia and Rest of Europe Markets –
Independent Analysis of Annual Sales in US$ Thousand for Years
2020 through 2027 and % CAGR
Table 44: Europe Historic Review for Radiation Therapy
Equipment by Geographic Region – France, Germany, Italy, UK,
Spain, Russia and Rest of Europe Markets – Independent Analysis
of Annual Sales in US$ Thousand for Years 2012 through 2019 and
% CAGR
Table 45: Europe 15-Year Perspective for Radiation Therapy
Equipment by Geographic Region – Percentage Breakdown of Value
Sales for France, Germany, Italy, UK, Spain, Russia and Rest of
Europe Markets for Years 2012, 2021 & 2027
Table 46: Europe Current & Future Analysis for Radiation
Therapy Equipment by Type – External Beam Radiation Therapy,
Internal Radiation Therapy and Systemic Radiation Therapy –
Independent Analysis of Annual Sales in US$ Thousand for the
Years 2020 through 2027 and % CAGR
Table 47: Europe Historic Review for Radiation Therapy
Equipment by Type – External Beam Radiation Therapy, Internal
Radiation Therapy and Systemic Radiation Therapy Markets –
Independent Analysis of Annual Sales in US$ Thousand for Years
2012 through 2019 and % CAGR
Table 48: Europe 15-Year Perspective for Radiation Therapy
Equipment by Type – Percentage Breakdown of Value Sales for
External Beam Radiation Therapy, Internal Radiation Therapy and
Systemic Radiation Therapy for the Years 2012, 2021 & 2027
Table 49: Europe Current & Future Analysis for Radiation
Therapy Equipment by End-Use – Hospitals and Other End-Uses –
Independent Analysis of Annual Sales in US$ Thousand for the
Years 2020 through 2027 and % CAGR
Table 50: Europe Historic Review for Radiation Therapy
Equipment by End-Use – Hospitals and Other End-Uses Markets –
Independent Analysis of Annual Sales in US$ Thousand for Years
2012 through 2019 and % CAGR
Table 51: Europe 15-Year Perspective for Radiation Therapy
Equipment by End-Use – Percentage Breakdown of Value Sales for
Hospitals and Other End-Uses for the Years 2012, 2021 & 2027
FRANCE
Table 52: France Current & Future Analysis for Radiation
Therapy Equipment by Type – External Beam Radiation Therapy,
Internal Radiation Therapy and Systemic Radiation Therapy –
Independent Analysis of Annual Sales in US$ Thousand for the
Years 2020 through 2027 and % CAGR
Table 53: France Historic Review for Radiation Therapy
Equipment by Type – External Beam Radiation Therapy, Internal
Radiation Therapy and Systemic Radiation Therapy Markets –
Independent Analysis of Annual Sales in US$ Thousand for Years
2012 through 2019 and % CAGR
Table 54: France 15-Year Perspective for Radiation Therapy
Equipment by Type – Percentage Breakdown of Value Sales for
External Beam Radiation Therapy, Internal Radiation Therapy and
Systemic Radiation Therapy for the Years 2012, 2021 & 2027
Table 55: France Current & Future Analysis for Radiation
Therapy Equipment by End-Use – Hospitals and Other End-Uses –
Independent Analysis of Annual Sales in US$ Thousand for the
Years 2020 through 2027 and % CAGR
Table 56: France Historic Review for Radiation Therapy
Equipment by End-Use – Hospitals and Other End-Uses Markets –
Independent Analysis of Annual Sales in US$ Thousand for Years
2012 through 2019 and % CAGR
Table 57: France 15-Year Perspective for Radiation Therapy
Equipment by End-Use – Percentage Breakdown of Value Sales for
Hospitals and Other End-Uses for the Years 2012, 2021 & 2027
GERMANY
Table 58: Germany Current & Future Analysis for Radiation
Therapy Equipment by Type – External Beam Radiation Therapy,
Internal Radiation Therapy and Systemic Radiation Therapy –
Independent Analysis of Annual Sales in US$ Thousand for the
Years 2020 through 2027 and % CAGR
Table 59: Germany Historic Review for Radiation Therapy
Equipment by Type – External Beam Radiation Therapy, Internal
Radiation Therapy and Systemic Radiation Therapy Markets –
Independent Analysis of Annual Sales in US$ Thousand for Years
2012 through 2019 and % CAGR
Table 60: Germany 15-Year Perspective for Radiation Therapy
Equipment by Type – Percentage Breakdown of Value Sales for
External Beam Radiation Therapy, Internal Radiation Therapy and
Systemic Radiation Therapy for the Years 2012, 2021 & 2027
Table 61: Germany Current & Future Analysis for Radiation
Therapy Equipment by End-Use – Hospitals and Other End-Uses –
Independent Analysis of Annual Sales in US$ Thousand for the
Years 2020 through 2027 and % CAGR
Table 62: Germany Historic Review for Radiation Therapy
Equipment by End-Use – Hospitals and Other End-Uses Markets –
Independent Analysis of Annual Sales in US$ Thousand for Years
2012 through 2019 and % CAGR
Table 63: Germany 15-Year Perspective for Radiation Therapy
Equipment by End-Use – Percentage Breakdown of Value Sales for
Hospitals and Other End-Uses for the Years 2012, 2021 & 2027
ITALY
Table 64: Italy Current & Future Analysis for Radiation Therapy
Equipment by Type – External Beam Radiation Therapy, Internal
Radiation Therapy and Systemic Radiation Therapy – Independent
Analysis of Annual Sales in US$ Thousand for the Years 2020
through 2027 and % CAGR
Table 65: Italy Historic Review for Radiation Therapy Equipment
by Type – External Beam Radiation Therapy, Internal Radiation
Therapy and Systemic Radiation Therapy Markets – Independent
Analysis of Annual Sales in US$ Thousand for Years 2012 through
2019 and % CAGR
Table 66: Italy 15-Year Perspective for Radiation Therapy
Equipment by Type – Percentage Breakdown of Value Sales for
External Beam Radiation Therapy, Internal Radiation Therapy and
Systemic Radiation Therapy for the Years 2012, 2021 & 2027
Table 67: Italy Current & Future Analysis for Radiation Therapy
Equipment by End-Use – Hospitals and Other End-Uses –
Independent Analysis of Annual Sales in US$ Thousand for the
Years 2020 through 2027 and % CAGR
Table 68: Italy Historic Review for Radiation Therapy Equipment
by End-Use – Hospitals and Other End-Uses Markets – Independent
Analysis of Annual Sales in US$ Thousand for Years 2012 through
2019 and % CAGR
Table 69: Italy 15-Year Perspective for Radiation Therapy
Equipment by End-Use – Percentage Breakdown of Value Sales for
Hospitals and Other End-Uses for the Years 2012, 2021 & 2027
UNITED KINGDOM
Market Overview
EXHIBIT 36: Number of New Cancer Cases Diagnosed (in Thousands)
in the UK: 2018
Market Analytics
Table 70: UK Current & Future Analysis for Radiation Therapy
Equipment by Type – External Beam Radiation Therapy, Internal
Radiation Therapy and Systemic Radiation Therapy – Independent
Analysis of Annual Sales in US$ Thousand for the Years 2020
through 2027 and % CAGR
Table 71: UK Historic Review for Radiation Therapy Equipment by
Type – External Beam Radiation Therapy, Internal Radiation
Therapy and Systemic Radiation Therapy Markets – Independent
Analysis of Annual Sales in US$ Thousand for Years 2012 through
2019 and % CAGR
Table 72: UK 15-Year Perspective for Radiation Therapy
Equipment by Type – Percentage Breakdown of Value Sales for
External Beam Radiation Therapy, Internal Radiation Therapy and
Systemic Radiation Therapy for the Years 2012, 2021 & 2027
Table 73: UK Current & Future Analysis for Radiation Therapy
Equipment by End-Use – Hospitals and Other End-Uses –
Independent Analysis of Annual Sales in US$ Thousand for the
Years 2020 through 2027 and % CAGR
Table 74: UK Historic Review for Radiation Therapy Equipment by
End-Use – Hospitals and Other End-Uses Markets – Independent
Analysis of Annual Sales in US$ Thousand for Years 2012 through
2019 and % CAGR
Table 75: UK 15-Year Perspective for Radiation Therapy
Equipment by End-Use – Percentage Breakdown of Value Sales for
Hospitals and Other End-Uses for the Years 2012, 2021 & 2027
SPAIN
Table 76: Spain Current & Future Analysis for Radiation Therapy
Equipment by Type – External Beam Radiation Therapy, Internal
Radiation Therapy and Systemic Radiation Therapy – Independent
Analysis of Annual Sales in US$ Thousand for the Years 2020
through 2027 and % CAGR
Table 77: Spain Historic Review for Radiation Therapy Equipment
by Type – External Beam Radiation Therapy, Internal Radiation
Therapy and Systemic Radiation Therapy Markets – Independent
Analysis of Annual Sales in US$ Thousand for Years 2012 through
2019 and % CAGR
Table 78: Spain 15-Year Perspective for Radiation Therapy
Equipment by Type – Percentage Breakdown of Value Sales for
External Beam Radiation Therapy, Internal Radiation Therapy and
Systemic Radiation Therapy for the Years 2012, 2021 & 2027
Table 79: Spain Current & Future Analysis for Radiation Therapy
Equipment by End-Use – Hospitals and Other End-Uses –
Independent Analysis of Annual Sales in US$ Thousand for the
Years 2020 through 2027 and % CAGR
Table 80: Spain Historic Review for Radiation Therapy Equipment
by End-Use – Hospitals and Other End-Uses Markets – Independent
Analysis of Annual Sales in US$ Thousand for Years 2012 through
2019 and % CAGR
Table 81: Spain 15-Year Perspective for Radiation Therapy
Equipment by End-Use – Percentage Breakdown of Value Sales for
Hospitals and Other End-Uses for the Years 2012, 2021 & 2027
RUSSIA
Table 82: Russia Current & Future Analysis for Radiation
Therapy Equipment by Type – External Beam Radiation Therapy,
Internal Radiation Therapy and Systemic Radiation Therapy –
Independent Analysis of Annual Sales in US$ Thousand for the
Years 2020 through 2027 and % CAGR
Please contact our Customer Support Center to get the complete Table of Contents
Read the full report: https://www.reportlinker.com/p05442588/?utm_source=GNW
About Reportlinker
ReportLinker is an award-winning market research solution. Reportlinker finds and organizes the latest industry data so you get all the market research you need – instantly, in one place.
__________________________
Artificial Intelligence
More than $9 Million Awarded to High School Scientists and Engineers at the Regeneron International Science and Engineering Fair 2024
Grace Sun, 16, receives $75,000 Top Award for a new kind of organic electrochemical transistor at the world’s largest pre-college science, technology, engineering and math (STEM) competition.
TARRYTOWN, N.Y. and WASHINGTON, May 17, 2024 /PRNewswire/ — Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) and Society for Science (the Society) announced that Grace Sun, 16, of Lexington, Kentucky, won the $75,000 top award, the George D. Yancopoulos Innovator Award, named in honor of the pioneering drug researcher and Regeneron co-Founder, Board co-Chair, President and Chief Scientific Officer, in the 2024 Regeneron International Science and Engineering Fair (Regeneron ISEF), the world’s largest pre-college science and engineering competition. Other top prizes went to projects in second-order cone programming, microplastics filtration and multi-sensory therapy for dementia.
The top winners were honored during two award ceremonies: the Special Awards on May 16 and the Grand Awards Ceremony on the morning of May 17. In total, over $9 million USD was awarded to the finalists based on their projects’ creativity, innovation and depth of scientific inquiry. The competition featured nearly 2,000 young scientists representing 49 U.S. states and nearly 70 countries, regions and territories across the world.
Grace Sun, 16, of Lexington, Kentucky, won first place and received the $75,000 George D. Yancopoulos Innovator Award for her research on building a better organic electrochemical transistor that she hopes will be used to develop new electronic devices that could help detect and treat serious illnesses like diabetes, epilepsy and organ failure. To overcome the problems that have previously prevented such devices from working effectively inside the body, Grace developed a new way of chemically treating their organic components, which greatly improved their laboratory performance.
Michelle Wei, 17, of San Jose, California, received one of two Regeneron Young Scientist Awards of $50,000 for her research to improve the speed and efficiency of a type of software that is useful in many fields such as machine learning, transportation and financial systems. Michelle’s new approach involved determining a quick approximate solution to the second-order cone programming problem, then splitting the initial cone into smaller cones, which enabled her new algorithm to greatly outperform previous approaches.
Krish Pai, 17, of Del Mar, California, received the second Regeneron Young Scientist Award of $50,000 for his machine-learning research to identify microbial genetic sequences that can be modified to biodegrade plastic. His new software, called Microby, scans databases of microorganisms and determines which ones can be changed genetically to biodegrade plastics. In tests, he identified two microorganisms that can be genetically modified to degrade plastic at a cost he believes would be ten times less than traditional recycling.
“Congratulations to the Regeneron International Science and Engineering Fair 2024 winners,” said Maya Ajmera, President and CEO, Society for Science and Executive Publisher, Science News. “I’m truly inspired by the ingenuity and determination shown by these remarkable students. Coming from around the world with diverse backgrounds and academic disciplines, these students have shown that it is possible to come together in unity to tackle some of the toughest challenges facing our world today, and I could not be prouder.”
Regeneron ISEF provides a global stage for the world’s best and brightest young scientists and engineers. Through this competition, Regeneron and the Society are fostering the next generation of STEM leaders who are pioneering solutions to improve our world. Since 2020, Regeneron has provided STEM experiences to approximately 2.4 million students, on track to meet its goal of 2.5 million by 2025.
“The talent, intelligence and potential of this year’s Regeneron ISEF finalists is truly inspiring, and I congratulate each on their remarkable achievements,” said George D. Yancopoulos, M.D., Ph.D., co-Founder, Board co-Chair, President and Chief Scientific Officer of Regeneron. “Science competitions like ISEF were pivotal in shaping my own career and fueling my passion to fight back against disease. I look forward to seeing these students continue to push the boundaries of science and technology to create positive and sustainable change for all humanity.”
Other top honors from the competition include:
Justin Huang and Victoria Ou, both 17, of Woodlands, Texas, received the Gordon E. Moore Award for Positive Outcomes for Future Generations of $50,000 for their new prototype filtration system that uses ultrasonic waves to remove microscopic plastic particles from water. In lab tests, the acoustic force from the high-frequency sound waves removed between 84% and 94% of the suspended microplastic particles in a single pass. The students are now working to scale up and fine-tune their experimental system.
Ingrid Wai Hin Chan, 17, of Hong Kong, China received the Craig R. Barrett Award for Innovation of $10,000 for her research on using a multi-sensory therapy for dementia patients. Her mixed therapy app would allow patients to practice physical and cognitive skills through a personalized, immersive environment using virtual reality headsets. Ingrid conducted an eight-week study with six people living with dementia and found that the cognitive function of patients who used her prototype improved in several areas. She believes her app could serve as a viable option for dementia patients with limited access to in-person professional therapy.
Tanishka Balaji Aglave, 15, of Valrico, Florida, received the H. Robert Horvitz Prize for Fundamental Research of $10,000 for her investigation into a natural alternative treatment against citrus greening, a disease that threatens citrus farming in many parts of the world and is currently only treated with antibiotics. Tanishka injected the trunks of infected trees with an extract from the curry leaf tree, and found through tests that this potential method could effectively and sustainably manage citrus greening disease.
Maddux Alexander Springer, 18, of Honolulu, Hawaii, received the Peggy Scripps Award for Science Communication of $10,000 for his research into fibropapillomatosis (FP), a disease that is the primary cause of death in green sea turtles. Some turtles he studied in Kaneohe Bay, Hawaii, were stricken with a disease that causes internal and external tumors that inhibit their everyday lives. After analyzing the turtles’ diet of green algae, Maddux concluded that this disease, wastewater, invasive algae and the amino acid arginine all pose a grave risk to these endangered sea creatures.
Ria Kamat, 17, of Hackensack, New Jersey; Anna Oliva, 17, of Houston, TX; and Shuhan Luo, 18, of Worcester, MA, received the Dudley R. Herschbach SIYSS Award, which provides finalists an all-expense paid trip to attend the Stockholm International Youth Science Seminar during Nobel Week in Stockholm, Sweden.
Jack Shannon, 18, of Clane, Kildare, Ireland, and Nikhil Vemuri, 17, of Cary, North Carolina, received the EU Contest for Young Scientists Award. Their projects will represent Regeneron ISEF at the EU Contest for Young Scientists to be held this September in Katowice, Poland.
For more information about the top winners and access to visual assets visit: https://www.societyforscience.org/isef-2024-media-kit.
The full list of Special Award ISEF 2024 Finalists can be found at https://www.societyforscience.org/press-release/regeneron-isef-2024-special-awards-winners.
In addition to the Top Award winners, more than 450 finalists received awards and prizes for their innovative research, including “First Award” winners, who each received a $5,000 prize.
The following lists the First Award winners for each of the 22 categories, from which the Top Awards were chosen:
Animal Sciences, sponsored by Society for ScienceMaddux Alexander Springer, Honolulu, Hawaii
Behavioral and Social Sciences, sponsored by Society for ScienceAndrew Y. Liang, San Jose, California
Biochemistry, sponsored by RegeneronAmy Hong Xiao, Garden City, New York
Biomedical and Health Sciences, sponsored by RegeneronRia Kamat, Hackensack, New Jersey; Kevin Xuan Lei, Shanghai, China
Biomedical Engineering, sponsored by Alfred E. Mann CharitiesAyush Garg, Dublin, California; Divij Motwani, Palo Alto, California; Akash Ashish Pai, Portland, Oregon
Cellular and Molecular Biology, sponsored by RegeneronLara and Maya Sarah Hammoud, Beverly Hills, Michigan
Chemistry, sponsored by Society for ScienceAkilan Sankaran, Albuquerque, New Mexico; Arjun Suresh Malpani and Siddharth Daniel D’costa, Portland, Oregon
Computational Biology and Bioinformatics, sponsored by RegeneronKun-Hyung Roh, Bronx, New York
Earth and Environmental Sciences, sponsored by Google.orgNikhil Vemuri, Durham, North Carolina; Justin Yizhou Huang and Victoria Ou, The Woodlands, Texas
Embedded Systems, sponsored by HPChloe Rae and Sophie Rose Filion, Welland, Ontario, Canada
Energy: Sustainable Materials and Design, sponsored by Siemens EnergyAlia Wahban, Hamilton, Ontario, Canada
Engineering Technology: Statics and Dynamics, sponsored by Howmet Aerospace FoundationChiyo Nakatsuji, Bunkyoku, Tokyo, Japan; Kevin Shen, Olympia, Washington
Environmental Engineering, sponsored by JacobsKrish Pai, San Diego, California; Jack Shannon, Clane, Kildare, Ireland
Materials Science, sponsored by Howmet Aerospace FoundationGrace Sun, Lexington, Kentucky
Mathematics, sponsored by Akamai FoundationAnna Oliva, Houston, Texas
Microbiology, sponsored by Schattner FoundationMatthew Chang, Irvine, California
Physics and Astronomy, sponsored by Richard F. Caris Charitable Trust IIHarini Thiagarajan and Vishal Ranganath Yalla, Bothell, Washington; Shuhan Luo, Worcester, Massachusetts
Plant Sciences, sponsored by Society for SciencePauline Estrada, Fresno, California; Tanishka Balaji Aglave, Dover, Florida
Robotics and Intelligent Machines, sponsored by RegeneronMichal Lajciak, Dubnica nad Vahom, Trenciansky kraj, Slovakia; Anthony Efthimiadis, Oakville, Ontario, Canada
Systems Software, sponsored by MicrosoftMichelle Wei, San Jose, California
Technology Enhances the Arts, sponsored by Society for ScienceAnant Khandelwal, Sritan Motati and Siddhant Sood, Alexandria, Virginia
Translational Medical Science, sponsored by RegeneronZheng-Chi Lee, West Lafayette, Indiana; Ingrid Wai Hin Chan, Hong Kong, China
The full list of all award-winning ISEF 2024 finalists is available here: https://www.societyforscience.org/press-release/regeneron-isef-2024-full-awards.
View all the finalists’ research here: https://projectboard.world/isef.
About the Regeneron International Science and Engineering FairThe Regeneron International Science and Engineering Fair (Regeneron ISEF), a program of Society for Science for over 70 years, is the world’s largest global science competition for high school students. Through a global network of local, regional and national science fairs, millions of students are encouraged to explore their passion for scientific inquiry. Each spring, a group of these students is selected as finalists and offered the opportunity to compete for approximately U.S. $9 million in awards and scholarships.
In 2019, Regeneron became the title sponsor of ISEF to help reward and celebrate the best and brightest young minds globally and encourage them to pursue careers in STEM to positively impact the world. Regeneron ISEF is supported by a community of additional sponsors, including Akamai Foundation, Alfred E. Mann Charities, Aramco, Caltech, Google.org, Gordon and Betty Moore Foundation, Howmet Aerospace Foundation, HP, , Jacobs, King Abdulaziz & his Companions Foundation for Giftedness and Creativity, Microsoft, National Geographic Society, Richard F. Caris Charitable Trust II, Rise, an initiative of Schmidt Futures and the Rhodes Trust, Schattner Foundation, Siemens Energy, Annenburg Foundation, Ballmer Group, Broadcom Foundation, Cesco Linguistic Services, Conrad N. Hilton Foundation, Edison International, Insaco, Oracle Academy, The Eli and Edythe Broad Foundation, The Ralph M. Parsons Foundation and US Army ROTC. Many are entrepreneurs across a wide range of industries. Learn more at https://www.societyforscience.org/isef/.
About Society for ScienceSociety for Science is a champion for science, dedicated to promoting the understanding and appreciation of science and the vital role it plays in human advancement. Established in 1921, Society for Science is best known for its award-winning journalism through Science News and Science News Explores, its world-class science research competitions for students, including the Regeneron Science Talent Search, the Regeneron International Science and Engineering Fair and the Thermo Fisher Scientific Junior Innovators Challenge, and its outreach and equity programming that seeks to ensure that all students have an opportunity to pursue a career in STEM. A 501(c)(3) membership organization, Society for Science is committed to inform, educate and inspire. Learn more at www.societyforscience.org and follow us on Facebook, Twitter, Instagram and Snapchat (Society4Science).
About RegeneronRegeneron (NASDAQ: REGN) is a leading biotechnology company that invents, develops and commercializes life-transforming medicines for people with serious diseases. Founded and led by physician-scientists, our unique ability to repeatedly and consistently translate science into medicine has led to numerous approved treatments and product candidates in development, most of which were homegrown in our laboratories. Our medicines and pipeline are designed to help patients with eye diseases, allergic and inflammatory diseases, cancer, cardiovascular and metabolic diseases, neurological diseases, hematologic conditions, infectious diseases and rare diseases.
Regeneron believes that operating as a good corporate citizen is crucial to delivering on our mission. We approach corporate responsibility with three goals in mind: to improve the lives of people with serious diseases, to foster a culture of integrity and excellence and to build sustainable communities. Regeneron is proud to be included on the Dow Jones Sustainability World Index and the Civic 50 list of the most “community-minded” companies in the U.S. Throughout the year, Regeneron empowers and supports employees to give back through our volunteering, pro bono and matching gift programs. Our most significant philanthropic commitments are in the area of early science education, including the Regeneron Science Talent Search and the Regeneron International Science and Engineering Fair (ISEF).
For more information, please visit www.Regeneron.com or follow Regeneron on LinkedIn, Instagram, Facebook or X.
More information about the top winners and access to visual assets visit: https://www.societyforscience.org/isef-2024-media-kit.
Media ContactsJoseph Brown, [email protected]
Gayle Kansagor, Society for [email protected]
Photo – https://mma.prnewswire.com/media/2416174/Regeneron_ISEF_2024_Winners_Photo.jpg
Logo – https://mma.prnewswire.com/media/2416197/Society_for_Science_Logo.jpg
View original content:https://www.prnewswire.co.uk/news-releases/more-than-9-million-awarded-to-high-school-scientists-and-engineers-at-the-regeneron-international-science-and-engineering-fair-2024-302149316.html
Artificial Intelligence
J.P. Morgan Life Sciences Private Capital, Blue Horizon Advisors and United Al Saqer Announce Winner of Inaugural 2024 Life Sciences Innovation Summit
In conjunction with Abu Dhabi Global Healthcare Week 2024
ABU DHABI, UAE, May 17, 2024 /PRNewswire/ — J.P. Morgan Life Sciences Private Capital, Blue Horizon Advisors and United Al Saqer Group announced today Rayees Rahman of Harmonic Discovery as the winner of the inaugural J.P. Morgan Asset Management: Life Sciences Innovation Summit. Harmonic Discovery is a precision pharmacology company applying its generative chemistry platform to advance next-generation kinase inhibitors.
In partnership with the Department of Health – Abu Dhabi (DoH), the Summit took place on May 14-15, 2024 at Cleveland Clinic Abu Dhabi and showcased the 11 innovative finalists, as well as highlighted existing innovators and opportunities in the Emirate of Abu Dhabi. The event also featured keynote speeches from Dr. Laurie Glimcher of Dana-Farber Cancer Institute, Dr. Shahrukh Hashmi of the Department of Health – Abu Dhabi, and Dr. David Ho of Columbia University Medical Center and provided attendees networking opportunities to gain valuable insights into the future of life sciences innovation.
In addition, the jury designated Chun-Hao Huang of Algen Biotechnologies as honourable mention. Algen Biotechnologies is a platform therapeutics and drug discovery company using world-leading CRISPR and AI to find treatments for cancer, inflammation and metabolic diseases.
The winners were selected by an esteemed, international panel of judges, which included:Laurie Glimcher, MD, President and CEO at Dana-Farber Cancer InstituteJorge Guzman, MD, CEO at Cleveland Clinic Abu DhabiProf. Shahrukh Khurshid Hashmi, MD, Director of Research, Department of Health, Abu DhabiYasmine Hayek Kobeissi, PhD, CQF, BSc., Executive Director at Blue Horizon AdvisorsAnya Schiess, Managing Partner at J.P. Morgan Life Sciences Private CapitalWalid Zaher, PhD, Co-Founder and CEO, Carexso
Dr. Asma Al Mannaei, Executive Director of the Research and Innovation Centre at the Department of Health – Abu Dhabi said: “Under the directives of the UAE’s wise leadership, and renowned for its world-leading medical infrastructure, Abu Dhabi stands at the forefront of healthcare excellence, offering an unparalleled opportunity for advancement in healthcare for global partners. It was our utmost pleasure hosting the J.P. Morgan Asset Management Life Sciences Innovation Summit 2024 on the sidelines of Abu Dhabi Global Healthcare Week and we commend the winners for their pioneering efforts in driving impactful advancements in healthcare; their dedication to innovation not only transforms the landscape of medicine, but also holds the promise of improving lives worldwide.”
Stephen Squinto, PhD, Chief Investment Officer, J.P. Morgan Life Sciences Private Capital said: “We are thrilled with the level of biotech passion and innovation that we observed at this year’s Summit in Abu Dhabi. The energy was truly palpable we are thrilled to announce Rayees Rahman as the winner of our first Life Sciences Innovation Summit. Harmonic Discovery’s approach embodies the next generation of drug discovery and development. We appreciate the time and effort of all participants and cannot wait for our next event in the region.”
Nabil Kobeissi, Chief Executive Officer of Blue Horizon Advisors, said: “As the main sponsor, we are committed to nurturing and fostering the growth of all 11 finalists in this vibrant biotech ecosystem. This Summit marks the beginning of a transformative journey, and we are confident that it will pave the way for a flourishing hub in the region. We are also pleased to announce that we will commit to invest in and partner with the winner, Harmonic Discovery, to support its future growth in the region.”
Sponsors for the event included J.P. Morgan Life Sciences Private Capital, J.P. Morgan Commercial Bank, Blue Horizon Advisors, United Al Saqer Group, Thermo Fisher Scientific, and Salam Capital. The Summit organisation, logistics and finalist recruitment were facilitated by Lyfebulb.
Of importance, at the Summit, Mr. Mohamed Al Breiki, Executive Director of Sustainable Development at Masdar City, announced that Masdar City Free Zone would award all 11 Finalists complimentary business licenses to further support their establishment in the region. Masdar City is one of the world’s most sustainable urban developments and innovation hubs with a growing focus on life science entrepreneurship in Abu Dhabi.
View original content:https://www.prnewswire.co.uk/news-releases/jp-morgan-life-sciences-private-capital-blue-horizon-advisors-and-united-al-saqer-announce-winner-of-inaugural-2024-life-sciences-innovation-summit-302149186.html
Artificial Intelligence
Congregating in the Lion City for a Win-Win Future of Intelligent Computing at the Global Data Center Facility Summit 2024
SINGAPORE, May 17, 2024 /PRNewswire/ — On May 17, 2024, the Global Data Center Facility Summit 2024 was held in Singapore with the theme of “Power the Digital Era Forward.” At the summit, over 600 data center industry leaders, technical experts, and ecosystem partners gathered to discuss new trends and opportunities of the global data center industry in the intelligent computing era. The attendees also got to experience all-scenario, all-ecosystem, and all-service end-to-end (E2E) solutions, share innovative practices of green data centers in the Asia Pacific and Europe, and experience the exhibition vehicle to unveil the mystery of Outdoor PowerPOD that features one power system per container. By fully embracing the intelligent computing era, Huawei strives to power the digital era forward.
Seizing Opportunities Brought by AI and Jointly Building Green & Reliable Computing Infrastructure
At the opening speech, Charles Yang, Senior Vice President of Huawei and President of Marketing, Sales and Services, Huawei Digital Power, noted that since ChatGPT ushered in the AI era, large models keep pushing the limits of computing power and the intelligent computing industry is witnessing an unprecedented construction boom. As predicted, 100 GW will be added to the global data center installed capacity and the market value will exceed US$600 billion in the next five years.
According to Charles, with opportunities come challenges. The primary challenge concerning the data center industry is reliability and electricity. Data centers are scaling up from the MW-level to the GW-level. E2E reliability of data centers is becoming even more important than ever. In response to the opportunities, Huawei will work with customers and partners to expand the industry space.
Steering Data Centers to the AI Era with Product + Service + Ecosystem
During the summit, Sun Xiaofeng, President of Huawei Data Center Facility & Critical Power Business, delivered a speech titled “Power the Digital Era Forward. ” He stated that as AI large models are penetrating, the surging compute demands drive the expansive growth in data center.
To address the challenges, Huawei strives to build product + service + ecosystem E2E data center solutions that feature fast deployment, flexible cooling, green energy, and ultimate reliability.
Fast deployment: Data centers are fully modularized and prefabricated to ensure high quality and efficient construction.Flexible cooling: Air-liquid fusion and integrated cooling source emerges as the optimal cooling architecture for intelligent computing.Green energy: New generation-grid-load-storage integrated solution is built to ensure the sound operations of intelligent computing centers.Ultimate reliability: Data centers are safeguarded through reliable products and preventive protection.Currently, Huawei’s global service network covers more than 170 countries with over 1800 professional engineers, providing 24/7 technical support. With N+ flagship service centers, Huawei has built a one-hour service radius for its customers.
The ecosystem is a key part for a win-win future of intelligent computing. Huawei works with partners to develop comprehensive E2E solutions and provide customers with one-stop data center services.
During the summit, Huawei and the ASEAN Centre for Energy released a white paper on “Building Next Generation Data Center Facility in ASEAN.” The document provides insights into the status quo, challenges, and trends of data centers in the ASEAN region, and emphasizes that efficient and energy-saving products and solutions should be applied. It also proposes future-oriented policy recommendations for data center markets.
In the ecosystem exhibition area, Huawei showcased scenario-based solutions for large-, medium-, and small-sized data centers, and demonstrated data center consulting, design, integrated development, and delivery capabilities with dozens of ecosystem partners including CIMC, Weichai, CSCEC, and Huashi.
On a special note, the Huawei Outdoor PowerPOD exhibition vehicle made its global debut. The Huawei Outdoor PowerPOD features one power system per container, outdoor deployment, plug-and-play, and high protection rating and reliability. It has become the preferred choice for decoupling the power supply architecture.
A single tree cannot make a forest.
AI is presenting great opportunities. By delving into the industry, aggregating partner ecosystems, and making innovations applicable to transformations, Huawei will continue to help customers build reliable computing infrastructure, accelerating the industry to embrace AI and powering the digital era forward.
Photo – https://mma.prnewswire.com/media/2415818/Global_Data_Center_Facility_Summit_2024.jpg
View original content:https://www.prnewswire.co.uk/news-releases/congregating-in-the-lion-city-for-a-win-win-future-of-intelligent-computing-at-the-global-data-center-facility-summit-2024-302148973.html
-
Uncategorized5 days agoCrossover Markets Becomes First Crypto ECN to Integrate with Talos
-
Artificial Intelligence5 days agoMSI Highlights Optimized AI Platforms to Accelerate Compute-Intensive Applications at ISC 2024
-
Uncategorized5 days ago
Precisely Showcases Critical Role of Trusted Data in AI at the Gartner® Data & Analytics Summit in London
-
Artificial Intelligence5 days agoAdvanced HPC Server Platforms by MiTAC and TYAN Spotlighted at ISC High Performance 2024
-
Uncategorized3 days ago
Artificial intelligence tool detects sex-related differences in brain structure
-
Artificial Intelligence7 days agoElevate Your Virtual Reality Experience with KIWI design RGB Vertical Stand, Now Available on Meta’s Website
-
Artificial Intelligence5 days agoLG CEO EMBARKS ON STRATEGIC U.S. VISIT TO ENHANCE AI INITIATIVES
-
Artificial Intelligence5 days ago
Supermicro’s Rack Scale Liquid-Cooled Solutions with the Industry’s Latest Accelerators Target AI and HPC Convergence
